Literature DB >> 16926838

Noninvasive system for evaluating allergen-induced nasal hypersensitivity in murine allergic rhinitis.

Muneo Nakaya1, Makoto Dohi, Katsuhide Okunishi, Kazuyuki Nakagome, Ryoichi Tanaka, Mitsuru Imamura, Shintaro Baba, Naonobu Takeuchi, Kazuhiko Yamamoto, Kimitaka Kaga.   

Abstract

Until now there has been no method for physiologically evaluating nasal hypersensitivity in mice. Enhanced pause (Penh) has been used as an indicator that reflects changes in the lower airway. Recently, however, there is disagreement regarding the significance of the Penh system; this is because Penh is not essentially a physiological parameter, and it might not necessarily represent a change in the lower respiratory tract. The purpose of the present study is to investigate whether Penh could be applicable for analyzing nasal hypersensitivity in mice. BALB/c mice were sensitized with ovalbumin (OVA) through a combination of intraperitoneal injection and daily intranasal challenge in an awake condition. Penh was measured at each time point during sensitization, or a serial change in Penh value was followed after the final nasal challenge and the effect of treatment was assessed. Following sensitization and nasal challenge, the Penh value gradually increased and showed a significant difference on day 14. Changes in IgE, eosinophil infiltration into nasal mucosa, and OVA-induced symptoms all strongly correlated with the increase in Penh. On day 19, after OVA nasal provocation, Penh gradually increased and reached maximal values 25 min after the challenge. Pretreatment with dexamethasone or a histamine H1 blocker significantly suppressed this increase in Penh. We confirmed that intranasal OVA challenge did not induce bronchoconstriction by measuring airway resistance and bronchoalveolar lavage fluid, and through histological examination. These results clearly demonstrate that Penh could be a useful noninvasive indicator for studying nasal hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926838     DOI: 10.1038/labinvest.3700452

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Airway responsiveness measured by barometric plethysmography in guinea pigs.

Authors:  Mario H Vargas; Bettina Sommer; Blanca Bazán-Perkins; Luis M Montaño
Journal:  Vet Res Commun       Date:  2010-07-13       Impact factor: 2.459

Review 2.  Rodent models of allergic rhinitis: relevance to human pathophysiology.

Authors:  James G Wagner; Jack R Harkema
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

3.  Inhalations with Brine Solution from the 'Wieliczka' Salt Mine Diminish Airway Hyperreactivity and Inflammation in a Murine Model of Non-Atopic Asthma.

Authors:  Dominika Zając; Ewelina Russjan; Magdalena Kostrzon; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

4.  Differentially expressed circular RNAs in a murine asthma model.

Authors:  Hui Bao; Qiuyan Zhou; Qiuju Li; Mengmeng Niu; Sanfeng Chen; Pingchang Yang; Zhigang Liu; Lixin Xia
Journal:  Mol Med Rep       Date:  2020-10-20       Impact factor: 2.952

5.  Does unrestrained single-chamber plethysmography provide a valid assessment of airway responsiveness in allergic BALB/c mice?

Authors:  Qingling Zhang; Kefang Lai; Jiaxing Xie; Guoqin Chen; Nanshan Zhong
Journal:  Respir Res       Date:  2009-07-03

6.  Mechanical Stimulation by Postnasal Drip Evokes Cough.

Authors:  Toshiyuki Iwata; Isao Ito; Akio Niimi; Koji Ikegami; Satoshi Marumo; Naoya Tanabe; Hitoshi Nakaji; Yoshihiro Kanemitsu; Hisako Matsumoto; Junzo Kamei; Mitsutoshi Setou; Michiaki Mishima
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

7.  Intranasal application of glucocorticoid alleviates olfactory dysfunction in mice with allergic rhinitis.

Authors:  Xiaowei Wang; Yingying Zhu; Daofeng Ni; Wei Lv; Zhiqiang Gao; Fang Qi
Journal:  Exp Ther Med       Date:  2017-08-28       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.